早期临床开发
RUO
自 2002 年起，安捷伦团队在美国科罗拉多州博尔德的 cGMP 工厂中为临床试验制造和提供寡核苷酸 API。制造实力强大，包括 11 套独立的设备，创建了 4 条不同的合成/纯化生产线及大规模冻干单元。
安捷伦的 77000 平方英尺工厂可为您的整个开发过程提供材料。利用适当规模的合成和纯化设备可为毒理学和早期临床开发提供中小规模量的产品。
安捷伦的 77000 平方英尺工厂可为您的整个开发过程提供材料。利用适当规模的合成和纯化设备可为毒理学和早期临床开发提供中小规模量的产品。
仅限研究使用。不可用于诊断目的。
- Oligonucleotide API Manufacturing
Product Details
Features
- 77000 平方英尺的 GMP 工厂为临床试验提供寡核苷酸 API
- 中小规模量
- 11 套独立的设备，创建了 4 条不同的合成/纯化生产线及两套冻干单元
Literature
- Brochures
-
Brochure - NASD - Delivering Solutions for Nucleic Acid Therapeutics
Nucleic Acid Solutions Division Overview Brochure.
- Brochures
- English
- 15 Jun 2020
- 3.37 MB
- Flyers
Customer Testimonials
Senior Director
Process chemistry
We like the collaborative nature of our partnership. Agilent works with us to truly understand our needs and how to best meet them, even when they change overtime.
View MoreSenior Vice President
Head of pharmaceutical Development
Collaborative. Adaptable. Reliable.
View MoreScientific Director
Analytical Development
Agilent provides program guidance and suggestions based on their extensive internal expertise, which helps avoid “re-inventing the wheel”.
View MoreTraining & Events
TIDES: Oligonucleotide and Peptide Therapeutics
Join more than 1,000 peers at this premier event for nucleic acids. Come and meet the team at our booth during TIDES at the Hynes Convention Center, Boston from May 11th to 14th 2020. Discover how Agilent can help you!
Webinar/Training
7th Annual Peptides & Oligonucleotides Congress
From April 27th to 29th 2020, you can find us at our booth during 7th Annual Peptides & Oligonucleotides Congress, London. Looking for some expert advice to advance your lead oligo candidates from clinic to market? Come talk to us!
Webinar/Training
AsiaTIDES: Oligonucleotide and Peptide Therapeutics
Drop by our booth from Feb 24th to 26th 2020 during AsiaTIDES. Hear about recent market developments and latest trends. Find out why more and more clients put their trust in Agilent to meet their clinical and commercial needs.
Webinar/Training
Promotions